Literature DB >> 20160840

Efficient Synthesis of the 2-amino-6-chloro-4-cyclopropyl-7-fluoro-5-methoxy-pyrido[1,2-c]pyrimidine-1,3-dione core ring system.

Jonathan D Rosen1, Nadezhda German, Robert J Kerns.   

Abstract

An optimized total synthesis of the 2-amino-6-chloro-4-cyclopropyl-7-fluoro-5-methoxy-pyrido[1,2-c]pyrimidine-1,3-dione core structure of a new fluoroquinolone-like class of antibacterial agents is described. This synthesis is highlighted by a nearly quantitative ring-closing reaction to form the pyrido[1,2-c]pyrimidine core. This bicyclic ring system serves as a scaffold for a family of biologically active compounds.

Entities:  

Year:  2009        PMID: 20160840      PMCID: PMC2631556          DOI: 10.1016/j.tetlet.2008.11.121

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  23 in total

1.  3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists.

Authors:  Vittoria Colotta; Daniela Catarzi; Flavia Varano; Francesca Romana Calabri; Guido Filacchioni; Chiara Costagli; Alessandro Galli
Journal:  Bioorg Med Chem Lett       Date:  2004-05-03       Impact factor: 2.823

2.  Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors.

Authors:  Tuan P Tran; Edmund L Ellsworth; Joseph P Sanchez; Brian M Watson; Michael A Stier; H D Hollis Showalter; John M Domagala; Martin A Shapiro; E Themis Joannides; Stephen J Gracheck; Dai Q Nguyen; Paul Bird; Judy Yip; Anurag Sharadendu; Chan Ha; Saeed Ramezani; Xiujuan Wu; Rajeshwar Singh
Journal:  Bioorg Med Chem Lett       Date:  2006-12-15       Impact factor: 2.823

3.  3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.

Authors:  Edmund L Ellsworth; Tuan P Tran; H D Hollis Showalter; Joseph P Sanchez; Brian M Watson; Michael A Stier; John M Domagala; Stephen J Gracheck; E Themis Joannides; Martin A Shapiro; Steve A Dunham; Debra L Hanna; Michael D Huband; Jeffrey W Gage; Joel C Bronstein; Jia Yeu Liu; Dai Q Nguyen; Rajeshwar Singh
Journal:  J Med Chem       Date:  2006-11-02       Impact factor: 7.446

4.  Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.

Authors:  Q Li; D T Chu; A Claiborne; C S Cooper; C M Lee; K Raye; K B Berst; P Donner; W Wang; L Hasvold; A Fung; Z Ma; M Tufano; R Flamm; L L Shen; J Baranowski; A Nilius; J Alder; J Meulbroek; K Marsh; D Crowell; Y Hui; L Seif; L M Melcher; J J Plattner
Journal:  J Med Chem       Date:  1996-08-02       Impact factor: 7.446

5.  In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.

Authors:  Michael D Huband; Michael A Cohen; Margaret Zurack; Debra L Hanna; Laura A Skerlos; Mark C Sulavik; Glenn W Gibson; Jeffrey W Gage; Edmund Ellsworth; Michael A Stier; Stephen J Gracheck
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

6.  Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol.

Authors:  Muhammad Malik; Tao Lu; Xilin Zhao; Anubha Singh; Christopher M Hattan; John Domagala; Robert Kerns; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 7.  Advances in DNA gyrase inhibitors.

Authors:  O K Kim; K Ohemeng; J F Barrett
Journal:  Expert Opin Investig Drugs       Date:  2001-02       Impact factor: 6.206

Review 8.  Fluoroquinolones: action and resistance.

Authors:  Karl Drlica; Muhammad Malik
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

Review 9.  Structure-activity and structure-side-effect relationships for the quinolone antibacterials.

Authors:  J M Domagala
Journal:  J Antimicrob Chemother       Date:  1994-04       Impact factor: 5.790

10.  Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.

Authors:  Katherine A Gould; Xiao-Su Pan; Robert J Kerns; L Mark Fisher
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

View more
  3 in total

1.  Comparison of in vitro activities of fluoroquinolone-like 2,4- and 1,3-diones.

Authors:  Lisa M Oppegard; Kathryn R Streck; Jonathan D Rosen; Heidi A Schwanz; Karl Drlica; Robert J Kerns; Hiroshi Hiasa
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

2.  Fluoroquinolone and quinazolinedione activities against wild-type and gyrase mutant strains of Mycobacterium smegmatis.

Authors:  Muhammad Malik; Kevin R Marks; Arkady Mustaev; Xilin Zhao; Kalyan Chavda; Robert J Kerns; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

Review 3.  Quinolones: action and resistance updated.

Authors:  Karl Drlica; Hiroshi Hiasa; Robert Kerns; Muhammad Malik; Arkady Mustaev; Xilin Zhao
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.